These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8263664)

  • 1. Evaluation of the influence of open and closed-ampoule technologies on particulate matter in small-volume parenterals.
    Bernuzzi M; Raggi P; Montanari L; Pregnolato F; Pavanetto F
    J Parenter Sci Technol; 1993; 47(5):265-9. PubMed ID: 8263664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particulate matter in small volume parenterals: evaluation of some technological and analytical aspects.
    Cirannni Signoretti E; Montanari I; Neri G; De Sena C; Alimonti S
    Boll Chim Farm; 1989 Feb; 128(2):65-70. PubMed ID: 2775519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy for reducing particulate contamination on opening glass ampoules and development of evaluation methods for its application.
    Lee KR; Chae YJ; Cho SE; Chung SJ
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1394-401. PubMed ID: 21702739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Devices for use in pharmaceutical filling machines to reduce the presence of particles glass in glass ampules].
    Lencioni E; Franchi G; Reghini A; Pezzuoli G
    Boll Chim Farm; 1983 Jan; 122(1):10-9. PubMed ID: 6882528
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study on insoluble microparticulate contamination at ampoule opening].
    Kawasaki Y
    Yakugaku Zasshi; 2009 Sep; 129(9):1041-7. PubMed ID: 19721379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological standards: problems in large-scale production.
    Campbell PJ
    Dev Biol Stand; 1976 Oct; 36():355-63. PubMed ID: 1030434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microbiological test for the determination of the maximum permissible standing time for non-sterilised ampoule solutions (author's transl)].
    Hecker W; Schiller I; Stemmer K; Urban S
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981 Sep; 173(6):412-8. PubMed ID: 7324609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particulate contamination of Australian ampoules.
    Gillies IR; Thiel WJ; Oppenheim RC
    J Pharm Pharmacol; 1986 Feb; 38(2):87-92. PubMed ID: 2870168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glass contamination in parenterally administered medication.
    Preston ST; Hegadoren K
    J Adv Nurs; 2004 Nov; 48(3):266-70. PubMed ID: 15488040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two methods of single-dose ampule opening and their influence upon glass particulate contamination.
    Giambrone AJ
    AANA J; 1991 Jun; 59(3):225-8. PubMed ID: 1950400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particulate and microbial contamination in in-use admixed intravenous infusions.
    Yorioka K; Oie S; Oomaki M; Imamura A; Kamiya A
    Biol Pharm Bull; 2006 Nov; 29(11):2321-3. PubMed ID: 17077539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of improved standardization methods and instrumentation in the USP particulate test for SVI.
    Barber TA; Lannis MD; Williams JG; Ryan JF
    J Parenter Sci Technol; 1990; 44(4):185-203. PubMed ID: 2213427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particulate contamination in New Zealand intravenous solutions.
    Passl WJ; Waring JM
    N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety concerns with glass particle contamination: improving the standard guidelines for preparing medication injections.
    Chiannilkulchai N; Kejkornkaew S
    Int J Qual Health Care; 2021 Jun; 33(2):. PubMed ID: 34101800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of methods for detection of particulate matter in large-volume perenterals.
    Blanchard J; Thompson CM; Schwartz JA
    Am J Hosp Pharm; 1976 Feb; 33(2):144-50. PubMed ID: 1258874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the adequacy of the draw-sealing of gas-filled glass ampoules.
    MacKenzie AP; Welkie DG; Lagally MG; Pace M; Elliott FI
    Dev Biol Stand; 1976 Oct; 36():151-60. PubMed ID: 1030414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.